Filing Details
- Accession Number:
- 0001209191-14-073199
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-04 18:17:52
- Reporting Period:
- 2014-12-02
- Filing Date:
- 2014-12-04
- Accepted Time:
- 2014-12-04 18:17:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1571498 | Epizyme Inc. | EPZM | Pharmaceutical Preparations (2834) | 261349956 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1619052 | Tai-Ching Peter Ho | C/O Epizyme, Inc. 400 Technology Square Cambridge MA 02139 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2014-12-02 | 200 | $21.19 | 200 | No | 4 | P | Direct | |
Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2014-12-02 | 400 | $21.16 | 400 | No | 4 | P | Indirect | By trust |
Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2014-12-02 | 400 | $21.16 | 400 | No | 4 | P | Indirect | By trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Indirect | By trust |
No | 4 | P | Indirect | By trust |
Footnotes
- These shares are held jointly with Dr. Ho's spouse.
- The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at prices of $21.15 per share to $21.17 per share. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- These shares are held in a trust for the benefit of the reporting person's child. The reporting person's spouse is a trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.